The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018

As part of the 2018 Immunotherapy Bridge congress (November 28–29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascierto, Paolo A., Butterfield, Lisa H., Demaria, Sandra, Ferris, Robert L., Freeman, Gordon J., Lo, Roger S., Mantovani, Alberto, Nathan, Paul, Hamid, Omid, Politi, Katerina, Puzanov, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696687/
https://www.ncbi.nlm.nih.gov/pubmed/31416487
http://dx.doi.org/10.1186/s40425-019-0683-0
_version_ 1783444310007480320
author Ascierto, Paolo A.
Butterfield, Lisa H.
Demaria, Sandra
Ferris, Robert L.
Freeman, Gordon J.
Lo, Roger S.
Mantovani, Alberto
Nathan, Paul
Hamid, Omid
Politi, Katerina
Puzanov, Igor
author_facet Ascierto, Paolo A.
Butterfield, Lisa H.
Demaria, Sandra
Ferris, Robert L.
Freeman, Gordon J.
Lo, Roger S.
Mantovani, Alberto
Nathan, Paul
Hamid, Omid
Politi, Katerina
Puzanov, Igor
author_sort Ascierto, Paolo A.
collection PubMed
description As part of the 2018 Immunotherapy Bridge congress (November 28–29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-cancer immune response; the merits of combination versus sequential immunotherapy regimens in the treatment of cancer; the advantages and disadvantages of murine models of cancer versus humans in order to evaluate immunotherapy; and whether or not mechanisms of resistance to immunotherapy differ between different cancers. Discussion of these important topics are summarised in this report.
format Online
Article
Text
id pubmed-6696687
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66966872019-08-19 The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018 Ascierto, Paolo A. Butterfield, Lisa H. Demaria, Sandra Ferris, Robert L. Freeman, Gordon J. Lo, Roger S. Mantovani, Alberto Nathan, Paul Hamid, Omid Politi, Katerina Puzanov, Igor J Immunother Cancer Review As part of the 2018 Immunotherapy Bridge congress (November 28–29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-cancer immune response; the merits of combination versus sequential immunotherapy regimens in the treatment of cancer; the advantages and disadvantages of murine models of cancer versus humans in order to evaluate immunotherapy; and whether or not mechanisms of resistance to immunotherapy differ between different cancers. Discussion of these important topics are summarised in this report. BioMed Central 2019-08-15 /pmc/articles/PMC6696687/ /pubmed/31416487 http://dx.doi.org/10.1186/s40425-019-0683-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Ascierto, Paolo A.
Butterfield, Lisa H.
Demaria, Sandra
Ferris, Robert L.
Freeman, Gordon J.
Lo, Roger S.
Mantovani, Alberto
Nathan, Paul
Hamid, Omid
Politi, Katerina
Puzanov, Igor
The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018
title The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018
title_full The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018
title_fullStr The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018
title_full_unstemmed The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018
title_short The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018
title_sort great debate at “immunotherapy bridge 2018”, naples, november 29th, 2018
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696687/
https://www.ncbi.nlm.nih.gov/pubmed/31416487
http://dx.doi.org/10.1186/s40425-019-0683-0
work_keys_str_mv AT asciertopaoloa thegreatdebateatimmunotherapybridge2018naplesnovember29th2018
AT butterfieldlisah thegreatdebateatimmunotherapybridge2018naplesnovember29th2018
AT demariasandra thegreatdebateatimmunotherapybridge2018naplesnovember29th2018
AT ferrisrobertl thegreatdebateatimmunotherapybridge2018naplesnovember29th2018
AT freemangordonj thegreatdebateatimmunotherapybridge2018naplesnovember29th2018
AT lorogers thegreatdebateatimmunotherapybridge2018naplesnovember29th2018
AT mantovanialberto thegreatdebateatimmunotherapybridge2018naplesnovember29th2018
AT nathanpaul thegreatdebateatimmunotherapybridge2018naplesnovember29th2018
AT hamidomid thegreatdebateatimmunotherapybridge2018naplesnovember29th2018
AT politikaterina thegreatdebateatimmunotherapybridge2018naplesnovember29th2018
AT puzanovigor thegreatdebateatimmunotherapybridge2018naplesnovember29th2018
AT asciertopaoloa greatdebateatimmunotherapybridge2018naplesnovember29th2018
AT butterfieldlisah greatdebateatimmunotherapybridge2018naplesnovember29th2018
AT demariasandra greatdebateatimmunotherapybridge2018naplesnovember29th2018
AT ferrisrobertl greatdebateatimmunotherapybridge2018naplesnovember29th2018
AT freemangordonj greatdebateatimmunotherapybridge2018naplesnovember29th2018
AT lorogers greatdebateatimmunotherapybridge2018naplesnovember29th2018
AT mantovanialberto greatdebateatimmunotherapybridge2018naplesnovember29th2018
AT nathanpaul greatdebateatimmunotherapybridge2018naplesnovember29th2018
AT hamidomid greatdebateatimmunotherapybridge2018naplesnovember29th2018
AT politikaterina greatdebateatimmunotherapybridge2018naplesnovember29th2018
AT puzanovigor greatdebateatimmunotherapybridge2018naplesnovember29th2018

Ejemplares similares